Large-scale external validation and meta-analysis of gene methylation biomarkers in tumor tissue for colorectal cancer prognosis
Open Access
- 24 June 2024
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 105, 105223
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Clinical significance of SPOP and APC gene alterations in colorectal cancer in Indian populationMolecular Genetics and Genomics, 2023
- DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicineInternational Journal of Cancer, 2022
- The extracellular matrix in tumor progression and metastasisClinical & Experimental Metastasis, 2019
- Clinical and prognosis value of the CIMP status combined with MLH1 or p16 INK4a methylation in colorectal cancerMedical Oncology, 2017
- Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumorsTumor Biology, 2015
- Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancerMedical Oncology, 2014
- The specific methylation characteristics of cancer related genes in Chinese colorectal cancer patientsTumor Biology, 2014
- Biological significance of promoter hypermethylation of p14/ARF gene: Relationships to p53 mutational status in Tunisian population with colorectal carcinomaTumor Biology, 2013
- Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker studyCellular Oncology, 2013
- MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancersCancer Causes & Control, 2010